Up 200% with a P/E of 8.5 and 5.3% yield – are NatWest shares still a screaming buy?

NatWest shares were starting to look a bit pricey and the yield was declining too, but after the last weeks’s results Harvey Jones likes the numbers now.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Image source: Getty Images

It’s been looking like NatWest (LSE: NWG) shares has run out of steam. That would hardly be a surprise, given how they’ve been racing along lately. The FTSE 100 banking stock is up an eye-popping 210% in five years, and 40% in the last 12 months, with dividends on top. Has it finally hit the buffers?

The shares are down almost 7% in the last month, as investors fret over the recent £2.7bn purchase of wealth manager Evelyn Partners, which it snapped up ahead of marauding Barclays. They fear NatWest CEO Paul Thwaite overpaid. The market’s response to last week’s full-year 2025 results (13 February) was also pretty downbeat. NatWest gave us plenty of whizzes and bangs, but not the full fireworks show. Yet I’m wondering if there’s one thing they’ve missed in all the noise.

Top FTSE 100 growth stock

When expectations are this high, even solid results disappoint. Typically, I’d expect a company that posted a 24.4% increase in pre-tax operating profits to £7.7bn, beating its own forecast of £7.5bn, to fly to the moon. Especially if it promised investors a £750m share buyback for the first half of its new financial year.

But markets were still biting their nails over Evelyn Partners, while some question the size of Thwaite’s £6.6bn pay packet, up 33%. The shadow of controversial RBS boss Fred Goodwin still hangs over the bank. He got £7.7m in 2006.

Net interest margins nudged up 21 basis points to 2.34%. That’s fine, but investors fear that will reverse as interest rates fall this year. It’s a threat across the banking sector, as it will narrow the gap between what they can pay savers and charge borrowers, which is a real money maker. This partly explains the Evelyn purchase, as Thwaite looks to find a new line of revenue in wealth management. Even though it already has private bank Coutts.

Dividends and buybacks too

There’s another reason investors are treading carefully. As the shares have soared, the trailing yield plunged towards 3%. But with the new results factored in, that’s climbed to 5.35%. NatWest is forecast to yield 5.86% across 2026, then 6.45% in 2027. Which looks a pretty solid rate of income to me, plus buybacks too.

The price-to-earnings ratio was climbing towards 15 but after last week’s results it’s dropped to just 8.5. That looks cracking value to me. It’s true that NatWest must work harder if interest rates continue to fall and the Evelyn bolt-on remains a concern. NatWest is primarily focused on the UK, which is in a sticky position economically. So growth may ease up.

Despite that, I’m keen. In fact, the only reason I won’t personally buy NatWest today is that I have a big stake Lloyds Banking Group, which has a similar domestic focus. Instead, I’ll target Barclays for its international reach. NatWest isn’t quite in screaming buy territory, I feel, but with a long-term view I see it as well worth considering today. The recent dip looks like an opportunity to get in at a decent valuation, and bag a higher yield too.

Harvey Jones has positions in Lloyds Banking Group Plc. The Motley Fool UK has recommended Barclays Plc and Lloyds Banking Group Plc. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Middle-aged white man pulling an aggrieved face while looking at a screen
Market Movers

Down 7%! Why on earth are Imperial Brands shares plummeting today?

Imperial Brands shares are in freefall after a negative reception to fresh trading news. Is the party finally over for…

Read more »

Rear View Of Woman Holding Man Hand during travel in cappadocia
Investing Articles

With a P/E under 7, this value stock looks far too cheap at 101p

This writer reckons value stock Hostelworld (LSE:HSW) looks dirt-cheap as it gets dividends flowing again and builds a social travel…

Read more »

Thoughtful man using his phone while riding on a train and looking through the window
Investing For Beginners

Down 30% in 6 months, I think there’s a big catch to this insanely cheap stock

Jon Smith talks through why careful research is needed when trying to assess if a cheap stock is worth buying…

Read more »

Investing Articles

£5,000 invested in National Grid shares 5 years ago is now worth…

Andrew Mackie takes a closer look at National Grid shares and why short-term market weakness could be missing a powerful…

Read more »

DIVIDEND YIELD text written on a notebook with chart
Investing Articles

How big does an ISA need to be to aim for a £1,500 monthly second income?

Harvey Jones shows how building a balanced portfolio of FTSE 100 dividend stocks can produce a high-and-rising second income in…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

£20,000 invested in BP shares 1 year ago is now worth…

BP shares have rocketed in the past 12 months, yet analysts think the real growth story is only just beginning,…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

A 6.8% forecast yield! 1 often-overlooked FTSE 100 income stock to buy today?

This income stock offers a high forecast yield and strengthening momentum, yet many investors overlook it — creating a rare…

Read more »

GSK scientist holding lab syringe
Investing Articles

GSK’s share price is under £22, but with a ‘fair value’ much higher, is it time for me to buy more right now? 

GSK’s share price rose over the last year, but a huge gap remains between its price and fair value —…

Read more »